{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:50:29Z","timestamp":1788292229614,"version":"build-2803163510"},"reference-count":38,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100007956","name":"Nanjing University of Chinese Medicine","doi-asserted-by":"publisher","award":["012009240034"],"award-info":[{"award-number":["012009240034"]}],"id":[{"id":"10.13039\/501100007956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Analytical Cellular Pathology"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Chemotherapy\u2010induced fatigue (CIF) remains a clinically challenging condition with limited therapeutic options. This study aimed to elucidate the therapeutic potential and underlying mechanisms of the multiherbal Xinlikang (XLK) capsule against CIF using an integrated strategy that combined network pharmacology prediction with experimental validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A murine CIF model was established using 5\u2010fluorouracil (5\u2010FU). XLK was administered at various doses to evaluate its efficacy through comprehensive assessments, including behavioral tests (weight\u2010bearing swimming, tail suspension, and grip strength), histopathology (hematoxylin\u2013eosin [H&amp;E] and periodic acid\u2010Schiff [PAS] staining), and metabolic indices (lactate and ATP levels). To investigate the mechanisms, an integrated network pharmacology approach was employed to identify bioactive components of XLK, predict their potential targets, and construct a \u201ccomponent\u2010target\u2010pathway\u201d network. Core signaling pathways implicated in CIF were prioritized via protein\u2013protein interaction (PPI) and KEGG enrichment analyses. Key predictions were subsequently verified by Western blot analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      XLK treatment significantly ameliorated fatigue\u2010like behaviors, improved muscle glycogen storage, and restored lactate and ATP homeostasis in CIF mice (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009 &lt; 0.05). Network pharmacology predicted that the anti\u2010CIF effect of XLK was closely associated with the regulation of energy metabolism\u2010related pathways, particularly the PI3K\/AKT\u2010mTOR\u2010FoxO signaling axis. Experimental validation confirmed that XLK significantly modulated the expression and phosphorylation levels of key proteins (e.g., p\u2010PI3K, p\u2010AKT, and p\u2010mTOR) within this pathway in the skeletal muscle or relevant tissues of CIF model mice (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009 &lt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>XLK enhances cellular energy homeostasis by regulating the PI3K\/AKT\u2010mTOR\u2010FoxO signaling axis, thereby alleviating CIF. These findings provide a mechanistic rationale for the clinical application of XLK against CIF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1155\/ancp\/8879160","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T06:27:31Z","timestamp":1771568851000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Xinlikang Capsule Alleviates Chemotherapy\u2010Induced Fatigue by Inhibiting the PI3K\/AKT\u2010mTOR\u2010FoxO Pathway"],"prefix":"10.1155","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2224-8061","authenticated-orcid":false,"given":"Suzhou","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7970-6781","authenticated-orcid":false,"given":"Tianle","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7679-835X","authenticated-orcid":false,"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihua","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaohong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1503-1384","authenticated-orcid":false,"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4901-1920","authenticated-orcid":false,"given":"Lina","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9380-8620","authenticated-orcid":false,"given":"Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"e_1_2_9_1_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-020-0707-5"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-39046-0"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2020.103707"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.02.016"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-022-01182-3"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu15010102"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.609705"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-5691.23.09983-5"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156213"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2024.138897"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117607"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.5014\/ajot.2023.77S10034"},{"key":"e_1_2_9_14_2","first-page":"1558","article-title":"Study on the Inhibitory Effect of Xinlikang Capsule on the Proliferation of Hematological Tumor Cells","volume":"22","author":"Tang X. X.","year":"2024","journal-title":"Central South Pharmacy"},{"key":"e_1_2_9_15_2","first-page":"48","article-title":"Studies on Main Pharmacodynamics of Xinlikang Capsule","volume":"24","author":"Li D. X.","year":"2018","journal-title":"Journal of Medicine & Pharmacy of Chinese Minorities"},{"key":"e_1_2_9_16_2","first-page":"312","article-title":"Effect of Xinlikang Capsules on Anti-Colon Cancer Andenhancing Immune Function","volume":"23","author":"Huang S. Z.","year":"2025","journal-title":"Central South Pharmacy"},{"key":"e_1_2_9_17_2","first-page":"16","article-title":"Clinical Observation of Xinlikang in the Treatment of Malignant Tumor","volume":"37","author":"Luo J. H.","year":"2018","journal-title":"Inner Mongolia Journal of Traditional Chinese Medicine"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-2647"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0216-7"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.781623"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1113\/JP278810"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.817916"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.30219"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.JCRT_151_19"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-016-0995-2"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2022.11.001"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu17071230"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells11091553"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201902102RR"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23760"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1250684"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2024.114261"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.04.036"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2020.8126"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.13968"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910359"},{"key":"e_1_2_9_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2021.03.018"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1142\/S0192415X23500507"}],"container-title":["Analytical Cellular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/ancp\/8879160","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1155\/ancp\/8879160","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/ancp\/8879160","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T21:10:48Z","timestamp":1773004248000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/ancp\/8879160"}},"subtitle":[],"editor":[{"given":"Jayachandran","family":"Jayakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1155\/ancp\/8879160"],"URL":"https:\/\/doi.org\/10.1155\/ancp\/8879160","archive":["Portico"],"relation":{},"ISSN":["2210-7177","2210-7185"],"issn-type":[{"value":"2210-7177","type":"print"},{"value":"2210-7185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-10-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"8879160"}}